AbCellera Biologics Inc. Common Shares
$7.580
USD
Last updated on --.
24h volume6.82M
24h highest6.9900 USD
24h lowest6.3500 USD
24h Price movement+9.38%
ABCL recent prices
24 Hours
+9.38%+$0.65
30 days
+11.47%+$0.78
60 days
+48.92%+$2.490
90 days
+44.38%+$2.330
Key data
Previous close6.9300 USD
Market cap1.74B USD
Volume6.82M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.47000 USD
Net income (FY)-143.96M USD
Revenue (FY)79.21M USD
Last report dateMay 11, 2026
About AbCellera Biologics Inc. Common Shares
HeadquartersVANCOUVER
Employees (FY)562.00
Revenue per employee (FY)140.94K USD
Net income per employee (FY)-256.15K USD
Listed onNasdaq
ABCL conversion tables
 |  |
|---|---|
| 0.5 ABCL | 3.790 USD |
| 1 ABCL | 7.580 USD |
| 5 ABCL | 37.9 USD |
| 10 ABCL | 75.8 USD |
| |
|---|---|
| 0.5 USD | 0.065963 ABCL |
| 1 USD | 0.13193 ABCL |
| 5 USD | 0.65963 ABCL |
| 10 USD | 1.319 ABCL |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ABCL is trading at $7.580, +9.38% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ABCL stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ABCL is currently trading at $7.580, +9.38% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ABCL price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ABCL's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ABCL; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ABCL's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
AbCellera Biologics Inc. Common Shares's market cap is currently 1.74B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume6.82M
24h highest6.9900 USD
24h lowest6.3500 USD
24h Price movement+9.38%
Start trade with ABCL Perpetual
Sign up to trade